Varex Imaging earnings date
Varex Imaging (VI4) Q2 2026 Earnings Report
DE:VI4 Q2 2026 EPS Results
- Actual EPS
- EUR 0.19
- Consensus EPS
- EUR 0.19
- Beat/Miss
- Met expectations
- One Year Ago EPS
- EUR 0.24
DE:VI4 Q2 2026 Revenue Results
- Actual Revenue
- EUR 195.25M
- Expected Revenue
- EUR 196.08M
- Beat/Miss
- Missed by -EUR 828.90K
- YoY Revenue Growth
- +1.46%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 05/07/2026
- Time
- After Close
- Conference Call
- Thursday, May 7, 2026
Varex Imaging's next earnings date is estimated for November 24, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
The call highlighted solid execution on guidance, margin resilience (non‑GAAP gross margin at the high end), successful debt refinancing and clear technology and industrial pipeline momentum (CT, photon-counting, cargo systems). Offsetting these positives are modest top‑line growth (+1% YoY), a GAAP loss, margin erosion versus the prior year (down ~240 bps), elevated inventory and short‑term working capital pressures. Management provided multi-quarter visibility (annual guidance) and actions (India ramp, pricing/contract renewal levers) that could improve margins over time, but near-term growth and margin recovery remain modest.
Varex guided that second‑half fiscal 2026 revenue should be up roughly 3% year‑over‑year (guidance excludes any IEEPA tariff refund) and reiterated full‑year fiscal 2026 revenues of $860–$880 million with non‑GAAP EPS of $0.80–$1.00; Q3 guidance is $210–$225 million of revenue and non‑GAAP diluted EPS of $0.15–$0.30, based on non‑GAAP gross margin of 33–34%, non‑GAAP operating expenses of about $54 million, net interest and other expense of $6–$7 million, a Q3 tax rate of ~23% (full‑year tax expectation ~20%), and roughly 42 million diluted non‑GAAP shares outstanding, and management said it will resume providing annual guidance going forward.
- Revenue Within Guidance and Continued DemandQ2 revenue of $216 million came in within guidance; total revenue increased 1% year-over-year, driven by medical (+2%) and industrial (+1%). Medical represented $156M (72% of total) and Industrial $60M (28%).
- Strong Non-GAAP Margin and EPS ExecutionNon-GAAP gross margin was 34% (at the high end of guidance) and non-GAAP EPS was $0.21, in-line with expectations.
- Improved Capital Structure via Debt RefinancingCompleted debt refinancing in the quarter, reducing outstanding debt and annual interest expense; gross debt $351M, cash & marketable securities $88M, net debt ~$263M — supporting greater financial flexibility.
- Profitability Metrics and LeverageAdjusted EBITDA was $27M (12% of sales) for the quarter; trailing 12‑month adjusted EBITDA was $118M and net debt leverage was ~2.2x adjusted EBITDA.
- Medical Product Momentum — CT and Photon CountingCT and radiography exceeded the company’s 5-quarter sales trend; CT remains a key growth driver. Photon-counting technology sales momentum remained strong with active engagement: 2 CT OEMs plus discussions with 8 additional OEMs across modalities.
- Industrial Segment Traction and PipelineIndustrial saw continued demand for tubes, linear accelerators, detectors and cargo security systems; company reported multiple new cargo inspection deals (including mobile systems and car scanners) and expects industrial to be an increasing driver of growth and margin expansion.
- Regional Strength in Americas and APACAmericas grew 13% YoY and APAC grew 8% YoY, providing geographic pockets of strong demand.
- Manufacturing Ramp in India Expected to Improve MarginsDetector factory in India completed and ramping (utilization currently low but expected to be materially utilized by year-end); company expects this to convert current gross margin and OpEx headwinds into tailwinds as utilization rises toward ~60–70%.
- Forward Guidance and Return to Annual Guidance PracticeCompany provided FY26 revenue guidance of $860M–$880M (second half revenue expected to be ~+3% YoY) and non-GAAP EPS guidance of $0.80–$1.00; management resumed providing an annual view citing improved visibility.
DE:VI4 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 24, 2026 | 2026 (Q4) | 0.26- | 0.33 | ― | ― |
| Aug 10, 2026 | 2026 (Q3) | 0.190.28 | 0.16 | 72.22% (+0.12) | |
| May 07, 2026 | 2026 (Q2) | 0.190.19 | 0.24 | -19.23% (-0.05) | |
| Feb 10, 2026 | 2026 (Q1) | 0.120.17 | 0.06 | 171.43% (+0.11) | |
| Nov 18, 2025 | 2025 (Q4) | 0.170.33 | 0.17 | 94.74% (+0.16) | |
| Aug 07, 2025 | 2025 (Q3) | 0.030.16 | 0.13 | 28.57% (+0.04) | |
| May 08, 2025 | 2025 (Q2) | 0.130.24 | 0.14 | 62.50% (+0.09) | |
| Feb 06, 2025 | 2025 (Q1) | 0.020.06 | 0.05 | 16.67% (+0.01) | |
| Nov 19, 2024 | 2024 (Q4) | 0.080.17 | 0.41 | -57.78% (-0.24) | |
| Aug 01, 2024 | 2024 (Q3) | 0.140.13 | 0.33 | -62.16% (-0.21) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.


